65 / 68
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 3, May/June 2015
AFRICA
e15
cardiac surgery.
Curr Surg
2004;
61
: 209–212.
9.
Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia
with unfractionated and low-molecular-weight heparin thromboprophy-
laxis: a meta-analysis.
Blood
2005;
106
: 2710–2715.
10. Aouifi A, Blanc P, Piriou V,
et al
. Cardiac surgery with cardiopulmonary
bypass in patients with type II heparin induced thrombocytopenia.
Ann
Thorac Surg
2001;
71
: 678–683.
11. Antoniou TH, Stavridis G, Daganou M, Melissari E, Gatzonis S.
Heparin-induced thrombocytopenia thrombosis after cardiac surgery. A
case report.
Acta Anaesthesiol Scand
2000;
44
: 991–993.
12. Cormack GM, Kaufman LJ. Severe heparin-induced thrombocytope-
nia: when the obvious is not obvious, a case report.
J Med Case Rep
2007;
1
: 13.
13. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A.
Evaluation of pretest clinical score (4 T’s) for the diagnosis of heparin-
induced thrombocytopenia in two clinical settings.
J Thromb Haemost
2006;
4
: 759–765.
14. Linkins LA, Dans AL, Moores LK,
et al
. Treatment and preven-
tion of heparin-induced thrombocytopenia: antithrombotic therapy
and prevention of thrombosis, 9th edn. American College of Chest
Physicians Evidence-Based Clinical Practice Guidelines.
Chest
2012;
141
: e495–530.